# SCGB1C2

## Overview
SCGB1C2 is a gene that encodes the protein secretoglobin family 1C member 2, which belongs to the secretoglobin family of small, secreted proteins. This protein is predominantly expressed in epithelial tissues, particularly within the respiratory and reproductive systems, where it is thought to play a role in cellular signaling and maintaining epithelial integrity. Secretoglobins, including SCGB1C2, are often associated with anti-inflammatory and immunomodulatory functions, contributing to tissue homeostasis and protection against environmental insults (Duek2018Exploring). While the precise functions of SCGB1C2 in humans are not fully understood, its involvement in sensory processes and chemical signaling has been suggested, particularly in relation to its expression in nasal mucosa and potential binding of small, hydrophobic molecules (Duek2018Exploring). The gene's clinical significance is under investigation, with potential implications in severe COVID-19 cases and challenges in protein identification due to sequence similarities with its paralog, SCGB1C1 (Siddiqui2018Chromosome; De2022Molecular).

## Function
SCGB1C2, a member of the secretoglobin family, is a small, secreted protein that is primarily expressed in epithelial tissues, particularly within the respiratory and reproductive systems. Although the specific function of SCGB1C2 in healthy human cells is not fully characterized, it is suggested to play roles in cellular signaling and maintaining epithelial integrity. Secretoglobins, including SCGB1C2, are often associated with anti-inflammatory and immunomodulatory functions, which may contribute to their role in maintaining tissue homeostasis and protecting epithelial surfaces from environmental insults (Duek2018Exploring).

SCGB1C2 has a paralog, SCGB1C1, which is regulated by inflammatory cytokines and is found in nasal mucosa. This suggests that SCGB1C2 might also be involved in similar regulatory pathways, potentially influencing immune responses or inflammation in epithelial tissues (Duek2018Exploring). The protein's expression in tissues associated with olfaction and its potential role in binding small, hydrophobic molecules, as seen in its rat ortholog, Ryd5, further imply a function related to sensory processes or chemical signaling (Duek2018Exploring). However, the exact molecular activities and cellular locations of SCGB1C2 in humans remain to be fully elucidated.

## Clinical Significance
SCGB1C2, a member of the secretoglobin family, has been implicated in various clinical contexts, although its specific roles remain largely uncharacterized. In the progression of COVID-19, SCGB1C2 is part of a gene module enriched in differentially expressed genes (DEGs) associated with extremely severe cases. This suggests a potential clinical significance in the context of severe COVID-19, although the exact function of SCGB1C2 in this setting is not yet understood (De2022Molecular).

The gene is also noted for its technical challenges in protein identification due to sequence similarities with its paralog SCGB1C1, complicating its study through mass spectrometry. This has hindered the ability to fully understand its clinical implications (Siddiqui2018Chromosome).

SCGB1C2's expression and potential functions have been explored in the context of olfactory processes, given its expression in nasal mucosa and regulation by inflammatory cytokines. Its role in binding small, hydrophobic odorant molecules has been proposed, although its presence in species lacking olfaction suggests alternative functions that remain to be elucidated (Duek2018Exploring). Despite these insights, the clinical significance of SCGB1C2 in specific diseases or conditions remains to be fully determined.


## References


[1. (Siddiqui2018Chromosome) Omer Siddiqui, Hongjiu Zhang, Yuanfang Guan, and Gilbert S. Omenn. Chromosome 17 missing proteins: recent progress and future directions as part of the next-mp50 challenge. Journal of Proteome Research, 17(12):4061–4071, October 2018. URL: http://dx.doi.org/10.1021/acs.jproteome.8b00442, doi:10.1021/acs.jproteome.8b00442. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/acs.jproteome.8b00442)

[2. (De2022Molecular) Ronika De and Rajeev K. Azad. Molecular signatures in the progression of covid-19 severity. Scientific Reports, December 2022. URL: http://dx.doi.org/10.1038/s41598-022-26657-2, doi:10.1038/s41598-022-26657-2. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-022-26657-2)

[3. (Duek2018Exploring) Paula Duek, Alain Gateau, Amos Bairoch, and Lydie Lane. Exploring the uncharacterized human proteome using nextprot. Journal of Proteome Research, 17(12):4211–4226, September 2018. URL: http://dx.doi.org/10.1021/acs.jproteome.8b00537, doi:10.1021/acs.jproteome.8b00537. This article has 37 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/acs.jproteome.8b00537)